SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-025879
Filing Date
2023-07-28
Accepted
2023-07-28 16:15:55
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1175380
2 CERTIFICATION ex31-1.htm EX-31.1 11257
3 CERTIFICATION ex31-2.htm EX-31.2 11431
4 CERTIFICATION ex32-1.htm EX-32.1 7716
5 CERTIFICATION ex32-2.htm EX-32.2 7444
6 form10-q_001.jpg GRAPHIC 5609
  Complete submission text file 0001493152-23-025879.txt   5209435

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20230630.xsd EX-101.SCH 31246
8 XBRL CALCULATION FILE mgrx-20230630_cal.xml EX-101.CAL 38697
9 XBRL DEFINITION FILE mgrx-20230630_def.xml EX-101.DEF 145547
10 XBRL LABEL FILE mgrx-20230630_lab.xml EX-101.LAB 304292
11 XBRL PRESENTATION FILE mgrx-20230630_pre.xml EX-101.PRE 226353
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 607290
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 231123252
SIC: 8090 Services-Misc Health & Allied Services, NEC